in the anterior pituitary do not secrete any known traditional pituitary hormones by themselves but exert inhibitory effects on the secretion of growth hormone (GH), prolactin (PRL), luteinizing hormone, or adrenocorticotropic hormone (ACTH) (1, 18). FSCs share similar characteristics with glial cells and, to some extent, with immune cells. For example, the glial protein S-100 is a specific marker for FSCs in the anterior pituitary (15). FSCs produce basic fibroblast growth factor (6) and possess nitric oxide synthase (4) as well as interleukin-6 (19). Several recent reports suggest that FSCs modulate hormone secretion through a paracrine mechanism within the anterior pituitary (17).
in the anterior pituitary do not secrete any known traditional pituitary hormones by themselves but exert inhibitory effects on the secretion of growth hormone (GH), prolactin (PRL), luteinizing hormone, or adrenocorticotropic hormone (ACTH) (1, 18) . FSCs share similar characteristics with glial cells and, to some extent, with immune cells. For example, the glial protein S-100 is a specific marker for FSCs in the anterior pituitary (15) . FSCs produce basic fibroblast growth factor (6) and possess nitric oxide synthase (4) as well as interleukin-6 (19) . Several recent reports suggest that FSCs modulate hormone secretion through a paracrine mechanism within the anterior pituitary (17) .
To date, it is poorly understood how the activity of FSCs is regulated. In the present study, we focused on the role played by ACh. ACh is synthesized by corticotrophs and by a subpopulation of lactotrophs in the anterior pituitary (3) . Cholinergic modulation of GH and PRL release in the anterior pituitary has been demonstrated (2, 11, 21) . Besides, muscarinic receptors have been found in rat anterior pituitary cells; however, their precise localization remains to be resolved (14, 16 
METHODS
Primary culture of rat anterior pituitary cells. The anterior pituitary was excised from male Wistar rats (250-300 g body wt) after decapitation by a guillotine. The pituitary was minced and incubated in 10 ml of Dulbecco's phosphatebuffered saline (Ϫ) (PBS, Nissui Pharmaceutical, Tokyo, Japan) containing 0.1% trypsin (type III, Sigma, St. Louis, MO) and 0.25% collagenase (type I, Sigma) for 20 min at 37°C with a gentle stirring. After the incubation, pieces of the pituitary were transferred into 10 ml of PBS supplemented with 0.1 mg/ml trypsin inhibitor (type II, Sigma) and 4 U/ml deoxyribonuclease I (Sigma) and were dispersed by triturating with a 5-ml plastic pipette for 5 min. After washing with PBS, the cells were plated on poly-L-lysine-coated glass coverslips and incubated in MEM (Nissui Pharmaceutical) supplemented with 2 mM L-glutamine, 4% normal rat serum, and 0.2% BSA (fraction V, Sigma) for 3-5 days at 37°C in a humidified atmosphere of 5% CO 2 -95% air. Identification of FSCs is described in RESULTS. Measurement of [Ca 2ϩ ] i . Details of the imaging technique and superfusion system have been described previously (9) . In brief, cultured cells were loaded by incubation with 1 M Fura PE-3 AM (TefLabs, Austin, TX) for 60 min at 37°C. The coverslip was placed in a small superfusion chamber on the stage of a Nikon Diaphot microscope. [Ca 2ϩ ] i was recorded by using the QuantiCell 700 system (Applied Imaging, Sunderland, UK). The cells were illuminated alternately at 340-nm and 380-nm excitation wavelengths, and then 510-nm emission light images were captured by an image-intensifying charge-coupled device camera (Photonics Science, Turnbridge Wells, UK). The time interval of each 340-to 380-nm ratio frame was 6 s. Ratios were converted to Ca 2ϩ concentrations by the following equation (7) (10) . Excess K ϩ solution was prepared by replacing Na ϩ with K ϩ in the control solution. The cells were continuously superfused at 37°C throughout the experiment, and the flow rate was ϳ1 ml/min. All drugs were applied through superfusion.
Drugs. The following drugs were purchased from Wako Chemicals (Osaka, Japan): ACh, thapsigargin, U-73343, U-73122, and pirenzepine. Nifedipine, neomycin, and ryanodine were purchased from Sigma. SKF-96365 was from Biomol Research Laboratories (Plymouth Meeting, PA). ] i in response to the first application and to the second challenge were designated as S 1 and S 2 , respectively, and the S 2 -to-S 1 ratio (S 2 /S 1 ) was determined. In some experiments, the effects of drugs introduced between the initial and second applications of ACh were evaluated by frequency histograms constructed for S 2 / S 1 . The data were expressed as means Ϯ SD. A paired t-test was used for statistical analysis. The significance level was set at P Ͻ 0.05.
RESULTS

Identification of FSCs in the cultured cells.
It has been demonstrated that FSCs have distinctive morphological characteristics in the pituitary (15) . In primary culture, FSCs extended thin cytoplasm (Fig. 1A , arrows). The thin cytoplasmic extension often formed processes in FSCs in culture. FSCs were confirmed by immunocytochemical staining of S-100 protein, a specific marker of FSCs in the anterior pituitary (Fig. 1B,  arrows) . Ca 2ϩ images are shown in pseudo-color ( Fig.  1, C-E) . FSCs responded to 300 nM ACh (Fig. 1D) but not to 50 mM K ϩ (Fig. 1E ). On the other hand, nonFSCs responded to 50 mM K ϩ but not to 300 nM ACh. The time course of the responses is shown in Fig. 2 , A and B. FSCs responded weakly to 50 mM K ϩ compared with non-FSCs. The average of peak ⌬[Ca 2ϩ ] i induced by 50 mM K ϩ was 42 Ϯ 28 nM (n ϭ 59 in 3 independent experiments) in FSCs and 646 Ϯ 234 nM (n ϭ 85 in 3 independent experiments) in non-FSCs (Fig. 2C) . Additionally, non-FSCs did not respond to 300 nM ACh in these 85 cells. In the present experiment, therefore, cells were designated as FSCs if they showed distinctive morphology and relative unresponsiveness to excess
] i , Ͻ100 nM). We tested the validity of these criteria in 85 cells and found that 84 of them were stained by antisera to S-100 protein.
ACh-induced rise in [Ca 2ϩ ] i . Representative responses to various concentrations of ACh are shown (Fig. 3A) . FSCs responded to ACh in a concentrationdependent manner at concentrations between 30 and 3,000 nM (Fig. 3B ] i followed by a sustained phase (Fig. 4A) . Similar responses were replicated by two sequential applications (Fig. 6A) . The peak ⌬[Ca 2ϩ ] i was 152 Ϯ 86 nM in the control and 134 Ϯ 55 nM in the Ca 2ϩ -free solution. The frequency distribution of S 2 /S 1 remained similar to that of control, and the average was 1.002 Ϯ 0.436 (n ϭ 53 in 5 independent experiments), as shown in Fig. 6B .
The effects of Ca 2ϩ channel blockers are shown in Fig. 7 . All blockers were applied to the bath 3 min before the second application of ACh. Gadolinium (100 M), a blocker of store-operated Ca 2ϩ channels, did not affect the initial rise of [Ca 2ϩ ] i but reversibly suppressed the following sustained increase (Fig. 7A) . The values of peak ⌬[Ca 2ϩ ] i were 220 Ϯ 105 nM in the control and 239 Ϯ 143 nM with gadolinium. S 2 /S 1 distributed similarly to the control, with an average of 1.068 Ϯ 0.508 (n ϭ 54 in 4 independent experiments) as shown in Fig. 7C . SKF-96365 (30 M), a blocker of store-operated Ca 2ϩ channels, also reversibly suppressed the sustained increase that followed (Fig. 7B) . It was noted that the initial rise was partially inhibited (P Ͻ 0.01). The peak ⌬[Ca 2ϩ ] i was 244 Ϯ 100 nM in the control and 181 Ϯ 98 nM after SKF-96365. The distribution of S 2 /S 1 shifted to the left, with an average of 0.813 Ϯ 0.399 (n ϭ 59 in 4 independent experiments) as shown in Fig. 7D . An L-type Ca 2ϩ channel blocker, nifedipine (10 M), had no effect. The peak ⌬[Ca 2ϩ ] i was 288 Ϯ 206 nM in the control and 318 Ϯ 214 nM with nifedipine. No difference was detected in the distribution of S 2 /S 1 (n ϭ 47 in 3 independent experiments).
The contribution of intracellular Ca 2ϩ stores was examined by experiments with thapsigargin, an inhibitor of endoplasmic reticulum Ca 2ϩ -ATPase (8) . Thapsigargin (1 M) was applied ϳ22 min before and throughout the second application of ACh. Thapsigar- gin alone caused a small and transient increase in [Ca 2ϩ ] i (Fig. 8) . Application of ACh, repeated after a 30-min interval, failed to induce any response in the presence of thapsigargin (n ϭ 60 in 3 independent experiments).
Phospholipase C inhibitors and ryanodine. Inhibitors of phospholipase C, neomycin and U-73122, were used to examine whether ACh activates phospholipase C in the FSCs. Prior superfusion with neomycin (3 mM) for 1 h inhibited the initial rise in [Ca 2ϩ ] i to 149 Ϯ 115 nM from the control of 246 Ϯ 135 nM (P Ͻ 0.01), which was partially reversed as shown in Fig. 9A . The distribution of S 2 /S 1 was shifted to the left with an average of 0.617 Ϯ 0.419 (n ϭ 61 in 4 independent experiments) as shown in Fig. 9D . U-73343 (10 M, 50-min prior superfusion), an inactive analog of U-73122, did not affect the response (Fig. 9B) . The peak ⌬[Ca ] i was similar to control, and the average was 1.002 Ϯ 0.436 (n ϭ 53 in 5 independent experiments). pholipase C, suppressed the response to 96 Ϯ 47 nM from a control of 177 Ϯ 66 nM (P Ͻ 0.01), which was reversed as shown in Fig. 9C . The distribution of S 2 /S 1 was shifted to the left, and the average was 0.570 Ϯ 0.230 (n ϭ 48 in 3 independent experiments) as shown in Fig. 9E .
Ryanodine ( 
DISCUSSION
The present experiments demonstrated that ACh increased [Ca 2ϩ ] i of FSCs in a concentration-dependent manner. Because this response was blocked completely by atropine and pirenzepine, the response is likely to be mediated by a muscarinic receptor. Piren- zepine is relatively specific to the M 1 receptor subtype but also blocks M 4 receptors with a similar potency (5). As we will discuss, the response of FSCs to ACh is likely to involve an activation of phospholipase C via G q/11 . Because M 1 but not M 4 receptors are coupled to G q/11 (20) , the present action of ACh is most likely mediated by the M 1 receptor.
The ] i in response to 50 mM K ϩ . In the present study, nifedipine, a blocker of the L-type Ca 2ϩ channel, did not affect the response at all. Based on the observation that two different inhibitors of phospholipase C, neomycin and U-73122, both suppressed the ACh-induced response, we propose that ACh activates phospholipase C and promotes production of D-myo-inositol 1,4,5-trisphosphate in the FSCs. It should be noted, however, that we found that U-73343, an inactive analog of U-73122, inhibited the response to ACh when U-73343 was present simultaneously with ACh (data not shown). This nonspecific action of U-73343 may be due to competitive inhibition on ACh action, because the inhibition was reversed by increasing the concentration of ACh (our preliminary results). We did not further investigate this point but simply washed out U-73343 before ACh application and found that the 10-min wash completely removed the nonspecific action of U-73343. Therefore, we applied U-73122 in the same time course as U-73343, which must reveal a specific action of U-73122 to inhibit phospholipase C.
An involvement of ryanodine receptors is unlikely, because ryanodine did not increase [Ca 2ϩ ] i of FSCs and did not affect the peak ⌬[Ca 
